Fig. 4From: Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patientsKaplan-Meier survival curve (in years) for a PS-matched subgroup diagnosed from 2011 to 2015, but with the surgery group limited to those who received MIE [SA-2]Back to article page